Mirae Asset Global ETFs Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-63	Closed	-$15.3K	–	3031
2025 Q1	$15.3K	Sell	63 -6	-9%	-$1.8K	﹤0.01%	3001
2024 Q4	$22.7K	Sell	69 -13	-16%	-$4.41K	﹤0.01%	2998
2024 Q3	$27.4K	Sell	82 -1,754	-96%	-$557K	﹤0.01%	3000
2024 Q2	$501K	Buy	+1,836	New	+$534K	﹤0.01%	1827

Other funds holding BIO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's BIO Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 63 shares — an estimated $15.3K sold.

Mirae Asset Global ETFs Holdings first reported a position in BIO in Q2 2024 and held it in 4 quarters. The position peaked at $501K in Q2 2024. 383 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

Mirae Asset Global ETFs Holdings reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
Mirae Asset Global ETFs Holdings sold 63 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $15.3K.
Mirae Asset Global ETFs Holdings first reported a position in Bio-Rad Laboratories Class A in Q2 2024 and held it in 4 quarters.
Mirae Asset Global ETFs Holdings's Bio-Rad Laboratories Class A position peaked at $501K in Q2 2024.
383 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.